Full Text View
Tabular View
Study Results
Related Studies
Bioequivalence Study of Zolpidem Tartrate Tablets and Ambien® Under Fasting Conditions
This study has been completed.
Study NCT00684814   Information provided by Mutual Pharmaceutical Company, Inc.

First Received on May 24, 2008.   Last Updated on April 18, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Healthy
Interventions listed in this trial
Zolpidem Tartrate 10 mg tablet
Additional drug interventions recognized in this trial
Zolpidem
More general drug interventions related to this trial
Central Nervous System Agents
Central Nervous System Depressants
GABA Agents
GABA Agonists
GABA-A Receptor Agonists
Hypnotics and Sedatives
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Mutual Pharmaceutical Company, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services